About Amundi DJ Switzerland Titans 30 UCITS ETF Distribution

C030 invests in stocks. The fund's major sectors are Health Technology, with 31.39% stocks, and Finance, with 25.38% of the basket. The assets are mostly located in the Europe region.

C030 top holdings are Roche Holding Ltd Dividend Right Cert. and Novartis AG, occupying 9.83% and 9.82% of the portfolio correspondingly.

C030 last dividends amounted to 2.41 EUR. The year before, the issuer paid 3.99 EUR in dividends, which shows a 65.91% decrease.

C030 assets under management is ‪173.55 M‬ EUR. It's risen 0.60% over the last month.

C030 fund flows account for ‪20.03 M‬ EUR (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.

C030 shares are issued by SAS Rue la Boétie under the brand Amundi. The ETF was launched on Dec 7, 2023, and its management style is Passive.

C030 expense ratio is 0.25% meaning you'd have to pay 0.25% of your investment to help manage the fund.

C030 follows the Dow Jones Switzerland Titans 30 Index - CHF. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.

C030 invests in stocks.

C030 price has fallen by −1.41% over the last month, and its yearly performance shows a 3.12% increase. See more dynamics on C030 price chart.
NAV returns, another gauge of an ETF dynamics, have risen by −1.12% over the last month, have fallen by −1.12% over the last month, showed a 2.95% increase in three-month performance and has increased by 6.19% in a year.